Elena Ratner
CIK: 0002049829
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ERNA
Ernexa Therapeutics Inc.
Director
Discretionary Trading P&L
Holdings
About Ratner Elena
Ratner Elena (SEC CIK 0002049829) files insider reports with the SEC as Director of Ernexa Therapeutics Inc. (ERNA).
Signal8 holds 3 ownership filings by Ratner Elena (1 Form 3, 2 Form 4), filed between Jan 14, 2025 and Sep 1, 2026. Those filings report 2 transactions, from Jan 13, 2025 to Aug 31, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ratner Elena's filings is in CAMBRIDGE, MA.
Recent filings by Ratner Elena
Other insiders filing for Ernexa Therapeutics Inc. (ERNA)
- Spiegel Robert J., Director
- Bristol James Arthur, Director
- Cicala Peter, Director
- Polinsky David, Director
- Wexler William A., Director
- Luther Sanjeev, President and CEO